acide kétoisocaproïque de taurine

Reported Uses

• NOTE: see Herb & Supplement Effectiveness Rating Definitions table
• academic performance [Insufficient Evidence]
• ADHD [Insufficient Evidence]
• age-related macular degeneration [Insufficient Evidence]
• androgenic alopecia [Insufficient Evidence]
• athletic performance [Insufficient Evidence]
• autism spectrum disorder [Insufficient Evidence]
• CHF [Possibly Effective]
• cirrhosis [Insufficient Evidence]
• cognitive function [Insufficient Evidence]
• cystic fibrosis [Insufficient Evidence]
• delirium [Insufficient Evidence]
• diabetes mellitus, type 2 [Insufficient Evidence]
• epilepsy [Insufficient Evidence]
• exercise-induced muscle soreness [Insufficient Evidence]
• fatigue [Insufficient Evidence]
• H. pylori infection [Insufficient Evidence]
• hepatitis [Possibly Effective]
• HTN [Insufficient Evidence]
• hyperlipidemia [Insufficient Evidence]
• infant development [Insufficient Evidence]
• iron deficiency anemia [Insufficient Evidence]
• muscular dystrophy [Insufficient Evidence]
• nausea/vomiting, chemo-related [Insufficient Evidence]
• nephrotoxicity, chemo-induced [Insufficient Evidence]
• obesity [Possibly Ineffective]
• physical performance [Insufficient Evidence]
• postop recovery [Insufficient Evidence]
• psychosis [Insufficient Evidence]
• sleep deprivation [Insufficient Evidence]
• Tourette syndrome [Insufficient Evidence]
• traumatic brain injury [Insufficient Evidence]